| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Alex D'Amico last filed a Form 4 in December 2022, as Chief Financial Officer at TCNNF. Alex D'Amico's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 82,869 shares of TCNNF. Net of sales, the TCNNF filings show accumulation of 2,820 shares.
Alex D'Amico has 6 Form 4 filings on record from May 2021 to December 2022, all as Chief Financial Officer at Trulieve Cannabis (TCNNF), 2021–2022.
The 8 reported transactions were 3 open-market purchases, 2 stock awards, 2 option or other derivative awards and 1 tax withholding.
Counted by filing, the open-market trades come to 3 purchases worth about $64K and no sales.
The largest open-market purchase was 660 shares of TCNNF at an average $38.00 on May 28, 2021, about $25K.
Shares as reported in the last Form 4 for each company; the most recent is from December 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 24, 2022 | TCNNF Trulieve Cannabis Corp. | Chief Financial Officer | Buy | 1,500 | $14.39 | $21,585.00 | +1.8% | |
| Aug 17, 2021 | TCNNF Trulieve Cannabis Corp. | Chief Financial Officer | Buy | 660 | $27.00 | $17,820.00 | +30.6% | |
| May 28, 2021 | TCNNF Trulieve Cannabis Corp. | Chief Financial Officer | Buy | 660 | $38.00 | $25,077.36 | +44.0% |